文献速递腹部PETMR

结直肠癌HER2状态个体化预测:基于18F-FDG PET/MR的影像组学模型开发与验证

Individualised prediction of HER2 status in colorectal cancer: development and validation of a radiomics prediction model using 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance (18F-FDG PET/MR).
PubMed 文献 · Clin Radiol · 2026-04-01

联合特征集的逻辑回归模型表现最佳,AUC达0.921,敏感度0.813,特异度0.942。SHAP分析显示分类贡献具有生物学合理性。

要点

  • PET/MR影像组学可无创术前预测结直肠癌HER2状态,联合特征逻辑回归模型AUC达0.921。
  • 联合PET、T1WI和T2WI特征优于单一序列特征集,支持多序列联合建模。
  • SHAP可解释性分析有助于理解影像组学特征与HER2状态的关联。

局限性

  • 单中心回顾性研究,样本量较小(98例),HER2阳性仅27例。
  • 未提及外部验证集,模型泛化能力有待多中心前瞻性研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Accurate, noninvasive preoperative identification of HER2 status in colorectal cancer (CRC) can support patient stratification and treatment planning.

MATERIALS AND METHODS: This study validated the value of radiomics derived from preoperative 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance (18F-FDG PET/MR) as an imaging surrogate for HER2 assessment in CRC. We retrospectively analysed 98 patients who underwent HER2 testing and PET/MR (27 HER2-positive, 71 HER2-negative). Radiomic features were extracted from PET, T1-weighted (T1WI), and T2-weighted (T2WI) images, and dimensionality reduction identified informative features. Twelve models were constructed by combining three classifiers (logistic regression (LR), random forest (RF), and support vector machine (SVM)) with four feature sets (PET-only, T1WI-only, T2WI-only, and combined) under stratified 5-fold cross-validation.

RESULTS: The LR model with combined features achieved the best performance (area under the curve (AUC) = 0.921; sensitivity (SEN) = 0.813; specificity (SPE) = 0.942; accuracy (ACC) = 0.907; F1-score 0.825). Model interpretability using SHapley Additive exPlanations (SHAP) highlighted biologically plausible image traits contributing to classification.

CONCLUSION: These findings indicate that PET/MR-based radiomics offers a noninvasive and interpretable approach for the preoperative evaluation of HER2 status in CRC patients.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yuan Z, Ding J, Cao Z, et al. Individualised prediction of HER2 status in colorectal cancer: development and validation of a radiomics prediction model using 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance (18F-FDG PET/MR). Clin Radiol. 2026. PMID: 42060950. doi:10.1016/j.crad.2026.107355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。